USANA Health Sciences, Inc. (USNA) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

USANA Health Sciences, Inc. (USNA) Consumer Business Overview

USANA Health Sciences, Inc. develops and distributes science-based nutritional and personal care products through direct sales. The company's key differentiators include its focus on high-quality ingredients, proprietary formulations, and a global distribution network, positioning it within the competitive packaged foods sector.

What Is the Investment Thesis for USNA?

USANA Health Sciences, Inc. presents a mixed investment thesis. The company's high gross margin of 76.7% indicates strong pricing power and efficient production. However, a low profit margin of 1.0% raises concerns about operational efficiency and cost management. The company's direct sales model offers growth potential in emerging markets, particularly in the Asia Pacific region. Key catalysts include expanding product lines and strategic partnerships. Potential risks include regulatory scrutiny, competition from established players, and reliance on its direct sales network. Investors should closely monitor sales growth, profitability trends, and regulatory developments.

Based on FMP financials and quantitative analysis

USNA Key Highlights

Market capitalization of $275M reflects its current valuation in the packaged foods sector.

• P/E ratio of 45.04 suggests a premium valuation compared to some peers, indicating investor expectations of future growth.
• Gross margin of 76.7% demonstrates strong pricing power and efficient cost of goods sold management.
• Profit margin of 1.0% indicates potential challenges in managing operating expenses and achieving higher profitability.
• Beta of 0.70 suggests lower volatility compared to the overall market, potentially appealing to risk-averse investors.

Who Are USNA's Competitors?

USNA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are USNA's Key Strengths?

Strong brand reputation for high-quality products.

• Global distribution network with a presence in key markets.
• Proprietary formulations and science-based approach.
• Direct sales network providing a competitive distribution advantage.

What Are USNA's Weaknesses?

Reliance on direct sales model, which can be susceptible to regulatory scrutiny.

• Relatively low profit margin compared to some competitors.
• Vulnerability to economic downturns affecting consumer spending.
• Potential for negative publicity related to distributor practices.

What Could Drive USNA Stock Higher?

USNA catalyst: Launch of new personalized nutrition products in Q3 2026, targeting a growing segment of health-conscious consumers.

• Expansion of the direct sales network in key Asian markets, driving revenue growth and market share.
• Continued investment in research and development to support product innovation and differentiation.
• Potential strategic partnerships with healthcare providers to expand distribution channels by Q4 2026.

What Are the Key Risks for USNA?

Negative return on equity (-4.2%) — the business is not currently generating profit on shareholder capital.

• Rich valuation — a P/E of 45.04 runs well above the Consumer Defensive sector’s ~27.60x, leaving little room for a miss.
• Regulatory scrutiny of the direct sales model and product claims could impact operations.
• Fluctuations in raw material costs and supply chain disruptions could affect profitability.
• Intense competition from established players and new entrants in the nutritional supplement market.
• Changes in consumer preferences and dietary trends could impact product demand.
• Negative publicity related to distributor practices or product safety could damage brand reputation.

What Are the Growth Opportunities for USNA?

• Expansion in Asia Pacific: USANA has a significant opportunity to expand its presence in the Asia Pacific region, driven by increasing disposable incomes and a growing demand for health and wellness products. The Asia Pacific dietary supplements market is projected to reach $97.2 billion by 2027. By leveraging its direct sales model and tailoring products to local preferences, USANA can capture a larger share of this market over the next 3-5 years.
• Product Innovation: Investing in research and development to introduce new and innovative products can drive revenue growth. USANA can capitalize on this trend by developing products that address specific health needs and incorporating cutting-edge scientific advancements. New product launches can attract new customers and increase sales within the next 2-3 years.
• Online Sales Growth: Enhancing its online sales platform and digital marketing efforts can expand USANA's reach and improve customer engagement. The global e-commerce market is growing rapidly, with online sales of dietary supplements increasing significantly. By investing in user-friendly websites, mobile apps, and targeted online advertising, USANA can drive online sales growth over the next 1-2 years.
• Strategic Partnerships: Forming strategic partnerships with healthcare providers, fitness centers, and other organizations can expand USANA's distribution network and increase brand awareness. Collaborating with established players in the health and wellness industry can provide access to new customer segments and enhance credibility. These partnerships can be established within the next year and contribute to long-term growth.
• Personalized Nutrition: Capitalizing on the trend towards personalized nutrition can differentiate USANA from its competitors and attract health-conscious consumers. By offering customized supplement recommendations based on individual health profiles and preferences, USANA can enhance customer loyalty and drive sales. The personalized nutrition market is expected to grow significantly in the coming years, and USANA can position itself as a leader in this space within the next 3-5 years.

What Are USNA's Competitive Advantages?

• Proprietary formulations and science-based approach.
• Direct sales network providing a competitive distribution advantage.
• Established brand reputation for high-quality products.
• Global distribution network with a presence in key markets.

What Does USNA Do?

USANA Health Sciences, Inc., founded in 1992 and headquartered in Salt Lake City, Utah, develops, manufactures, and sells science-based nutritional and personal care products. The company's core business revolves around providing high-quality supplements, personal care items, and related products through a direct sales model. USANA's product portfolio includes USANA nutritional products, featuring essentials/CellSentials—vitamin and mineral supplements designed for various age groups, optimizers—targeted supplements addressing cardiovascular, skeletal/structural, and digestive health needs, and foods such as meal replacement shakes and snack bars. Additionally, USANA offers Celavive, a skin care regimen catering to diverse skin types and ethnicities, along with products for prenatal, infant, and young child age groups. The company supports its associates with materials and online tools to facilitate business building and product marketing. USANA operates directly in the Asia Pacific, the Americas, and Europe, leveraging both physical distribution and online channels. USANA has established research collaborations, including an agreement with Beijing University of Chinese Medicine, to further its research in traditional Chinese medicine. The company also partners with the National Sports Training Bureau.

What Products and Services Does USNA Offer?

• Develops and manufactures science-based nutritional supplements.
• Offers a range of vitamin and mineral supplements for various age groups.
• Provides targeted supplements for cardiovascular, skeletal, and digestive health.
• Produces meal replacement shakes, snack bars, and related food products.
• Offers Celavive, a skin care regimen for different skin types and ethnicities.
• Provides products for prenatal, infant, and young child age groups.
• Offers materials and online tools to assist associates in building their businesses.
• Markets products directly in the Asia Pacific, the Americas, and Europe, as well as online.

How Does USNA Make Money?

• Direct sales through a network of independent distributors.
• Manufacturing and selling nutritional and personal care products.
• Online sales through the company's website.
• Research and development of new products.

What Industry Does USNA Operate In?

USANA Health Sciences, Inc. operates within the global packaged foods industry, which is characterized by increasing demand for health and wellness products. The market is driven by rising health awareness, aging populations, and growing disposable incomes, especially in emerging economies. The competitive landscape includes major players like Herbalife Nutrition (HLF) and Nu Skin Enterprises (NUS), as well as numerous smaller companies. USANA differentiates itself through its science-based formulations, direct sales model, and global distribution network. The industry faces challenges such as evolving consumer preferences, regulatory scrutiny, and supply chain disruptions.

Who Are USNA's Key Customers?

• Individuals seeking nutritional supplements and personal care products.
• Health-conscious consumers.
• Independent distributors who sell USANA products.
• Customers in the Asia Pacific, the Americas, and Europe.

Over the past six months, USANA Health Sciences, Inc. insiders filed 30 SEC Form 4 transactions — 21 sales and 9 purchases. On net that is roughly 30K shares disposed (about $580K), a signal worth weighing alongside the fundamentals.

Quarterly Financial Performance: USANA Health Sciences, Inc.

Revenue for USANA Health Sciences, Inc. came in at $223.3M during Q2 FY2026, a 10.8% contraction versus the preceding quarter. The company recorded a net loss of $21.4M, with diluted EPS of $-1.16. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Defensive. Across the four most recent quarters, USNA averaged $-0.30 in diluted EPS.

USNA Valuation & Market Position

With a $275M market cap, USANA Health Sciences, Inc. sits in the micro-cap segment of the market. Relative to its peer group, USNA's quantitative score of 61/100 is above the peer average of 50/100.

Return on equity for USANA Health Sciences, Inc. stands at -4.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -3.2%, showing how much profit it generates from its asset base. Its free cash flow yield is 5.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.66 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -8.0%, the inverse of the P/E and a quick read on earnings relative to price.

USANA Health Sciences, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.78 places it in the safe zone, indicating low near-term bankruptcy risk.

USANA Health Sciences, Inc. has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 13.1% below estimates on average.

Wall Street analysts project USANA Health Sciences, Inc. revenue of about $909.6M for fiscal 2027, with EPS near $0.76.

Company Profile

USANA Health Sciences, Inc. operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Salt Lake City, US. The company is led by CEO Kevin G. Guest. USNA has traded publicly since 1994.

USNA Financials

USNA Latest News

USNA Analyst Consensus

USNA MoonshotScore

What Investors Ask About USANA Health Sciences, Inc. (USNA) — Consumer Defensive

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources